The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Another Spire Healthcare Doctor Suspended Amid Care Concerns

Mon, 17th Feb 2020 11:46

(Alliance News) - Private healthcare company Spire Healthcare Group PLC said Monday it has suspended one of its doctors after concerns emerged over his work at a Leeds hospital.

Mike Walsh was suspended in April 2018 after close to 50 of his patients were recalled.

A Spire spokesperson said: "After concerns were raised about Walsh, an investigation was started in April 2018, and he was suspended immediately. We asked the Royal College of Surgeons to assist with this investigation and have shared the findings with the [Care Quality Commission] and the [General Medical Council].

"Where we have identified concerns about the care a patient received, we have invited the patient to an appointment with an independent surgeon to review their treatment. This is a complex case and the review is on-going.

The BBC said "details emerged" after an independent inquiry into Ian Paterson - now in jail.

Paterson previously worked at Spire and was found guilty in 2017 of intentionally wounding his patients through unnecessary and unregulated mastectomies.

Additionally, Habib Rahman, an orthopaedic consultant suspended by Spire in January 2019, has had more than 200 patients recalled following a Royal College of Surgeons investigation into potentially unnecessary procedures. At that time, Spire said it was not expecting to to have a material financial exposure to the recall.

The spokesperson for Spire said the company "reiterates its sincere apologies to those patients who have been affected by the treatment they received from Walsh" and urged patients treated by Walsh to contact the Leeds hospital.

Shares in Spire were down 0.2% at 129.61 pence in London on Monday.

By Anna Farley; annafarley@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

Related Shares

More News
3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

2 May 2024 13:48

UK shareholder meetings calendar - next 7 days

2 May 2024 13:44

UK earnings, trading statements calendar - next 7 days

22 Apr 2024 10:21

eEnergy jumps on GBP5.2 million contract with Spire Healthcare

(Alliance News) - eEnergy Group PLC shares jumped on Monday, after it said it has won a GBP5.2 million contract with Spire Healthcare Group PLC.

22 Apr 2024 07:41

LONDON BRIEFING: Hipgnosis supports Blackstone takeover bid

(Alliance News) - Stocks in London are called to open higher, as investors eye some key FTSE 250 takeovers.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.